PAVmed Inc. (NASDAQ:PAVM) will release its earnings data after the market closes on Monday, August 14th. Analysts expect PAVmed to post earnings of ($0.14) per share for the quarter.

Shares of PAVmed Inc. (PAVM) traded down 9.8032% during mid-day trading on Friday, hitting $2.8412. The stock had a trading volume of 2,240 shares. PAVmed Inc. has a 12-month low of $2.54 and a 12-month high of $14.49. The company has a 50 day moving average price of $3.99 and a 200 day moving average price of $4.96. The firm’s market cap is $37.88 million.

Separately, ValuEngine downgraded PAVmed from a “sell” rating to a “strong sell” rating in a report on Friday, July 28th.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at

About PAVmed

PAVmed Inc operates as a medical device company in the United States. Its product pipeline includes PortIO, a long-term implantable vascular access device; CarpX, a percutaneous device to treat carpal tunnel syndrome; NextCath, a self-anchoring catheter; DisappEAR: Antibiotic-eluting resorbable ear tube; NextFlo, a disposable infusion pump; and Caldus, a disposable tissue ablation device.

Receive News & Ratings for PAVmed Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.